2025. A Prospective Observational Study of Anthropometric Parameters in Patients with Type 2 Diabetes Mellitus Receiving Dipeptidyl Peptidase-4 Inhibitors: Research Article. Journal of Pharma Insights and Research. 3, 6 (Dec. 2025), 225–230. DOI:https://doi.org/10.69613/wq9ask44.